CORRECTING and REPLACING Expensify Announces Q4 and Full Year Fiscal 2021 Results
Ended the year with
The updated release reads:
EXPENSIFY ANNOUNCES Q4 AND FULL YEAR FISCAL 2021 RESULTS
Ended the year with
“The major highlight of 2021 was releasing our Free Plan in October and growing it to more than 3,100 customers by year end,” says
“We’re proud to have ended 2021 with a bang,” says
Financial
Q4 2021:
-
Revenue was
, an increase of$40.4 million 56.0% from the same period last year. -
An IPO-related bonus expense of
impacted net (loss) income.$14.2 million -
Net (loss) income was
, compared to$(21.9) million for the same period last year. The loss was primarily due to the IPO-related bonus.$1.7 million -
Non-GAAP net income was
. Non-GAAP net income excludes stock based compensation which was not excluded in prior periods.$4.4 million
-
Non-GAAP net income was
-
Adjusted EBITDA was
, compared to$(6.9) million for the same period last year.$10.2 million -
Adjusted EBITDA excluding the IPO bonus was
, compared to$7.3 million for the same period last year.$10.2 million
Full Year Fiscal 2021:
-
Revenue was
, an increase of$142.8 million 61.8% from the same period last year. -
An IPO-related bonus expense of
impacted net (loss) income and Adjusted EBITDA.$48.4 million -
Net loss was
, compared to$(13.6) million for the same period last year. The loss was primarily due to the IPO-related bonus.$(1.7) million -
Non-GAAP net income was
.$49.4 million
-
Non-GAAP net income was
-
Adjusted EBITDA was
, compared to$9.5 million for the same period last year.$26.8 million -
Adjusted EBITDA excluding the IPO bonus was
, compared to$58.0 million for the same period last year.$26.8 million
Business
- Paid members - saw major growth, with 711 thousand in the fourth quarter of 2021.
-
Free plan - launched in October and grew to over 3,100 customers by
December 2021 . Includes expense management, the Expensify Card, next-day reimbursement, invoicing, bill pay, and travel booking. -
Expensify Card - adoption continued at a rapid pace and interchange increased by
185% in 2021. -
Cash back - introduced unlimited cash back on the Expensify Card, with an introductory rate of
4% followed by an ongoing rate of2% across all purchases and categories. - Invoicing and bill pay - completed Expensify’s expansion into accounts payable and receivable, rounding out its offerings as a full-service preaccounting platform.
- New.expensify.com - launched a sneak peek of Expensify’s future product that mixes chat and payments for easy financial collaboration across work and personal life.
- Expensify.org - funded more than 50 grassroots organizations fighting injustice in their communities, reimbursed thousands of families on SNAP/EBT for groceries and COVID-19 vaccinations, and donated clothing to people experiencing homelessness.
- Podcast - aired first season of “Live Rich, Have Fun, Save the World,” which features individual trailblazers pursuing the lofty goals aligned with Expensify’s three-part company mission.
- ESG - reached carbon neutrality via offsets in 2021 and set a goal of Net Zero emissions by 2030.
- Customer support - won “Best Customer Support” from TrustRadius.
-
Operational efficiency - annualized revenue per employee topped
.1MM.$1 -
Calculated as three months ended
December 31, 2021 revenue multiplied by four (quarters), divided by 144 full-time employees as ofDecember 31, 2021 .
-
Calculated as three months ended
Financial Outlook
For the fiscal first quarter ending
-
Revenue between
and$38.6 million .$39.6 million - Average monthly paid members between 684 thousand and 702 thousand.
Availability of Information on Expensify’s Website
Investors and others should note that
Conference Call
Non-GAAP Financial Measures
In addition to financial measures prepared in accordance with
We believe our non-GAAP financial measures are useful in evaluating our business, measuring our performance, identifying trends affecting our business, formulating business plans and making strategic decisions. Accordingly, we believe that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating our results of operations in the same manner as our management team. These non-GAAP financial measures are presented for supplemental informational purposes only, should not be considered a substitute for financial information presented in accordance with GAAP, and may be different from similarly titled metrics or measures presented by other companies. Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as substitutes for financial information presented under GAAP. There are a number of limitations related to the use of non-GAAP financial measures versus comparable financial measures determined under GAAP. For example, other companies in our industry may calculate these non-GAAP financial measures differently or may use other measures to evaluate their performance. All of these limitations could reduce the usefulness of these non-GAAP financial measures as analytical tools. Investors are encouraged to review the related GAAP financial measures and the reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures and to not rely on any single financial measure to evaluate our business. A reconciliation of each non-GAAP financial measure to the most directly comparable financial measure stated in accordance with GAAP is at the end of this press release.
We define Adjusted EBITDA as net income from operations excluding provision for income taxes, interest and other expenses, net, depreciation and amortization and stock based compensation.
We define Adjusted EBITDA excluding the IPO-related bonus as net income from operations excluding provision for income taxes, interest and other expenses, net, depreciation and amortization, stock based compensation, and IPO-related bonus costs.
We define non-GAAP net income as net income from operations in accordance with US GAAP excluding stock-based compensation and IPO-related bonus costs. In prior periods, this metric only excluded IPO-related bonus costs and did not exclude expenses related to stock-based compensation. However, management now believes that further excluding stock-based compensation from non-GAAP net income is useful to better understand the financial performance of our business and to facilitate a better comparison of our results to those of peer companies over multiple periods given that this item may vary between companies for reasons unrelated to overall operating performance.
The tables at the end of the Financial Statements provide reconciliations to the most directly comparable GAAP financial measure to each of these non-GAAP financial measures.
Forward-Looking Statements
Forward-looking statements in this press release, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1955. These statements include statements regarding our strategy, future financial condition, future operations, projected costs, prospects, plans, objectives of management and expected market growth and involve known and unknown risks that are difficult to predict. As a result, our actual results, performance or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “may,” “will,” “shall,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” “goal,” “objective,” “seeks,” or “continue” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans, or intentions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by us and our management, are inherently uncertain. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: the economic, political and social impact of, and uncertainty relating to, the COVID-19 pandemic; the war in
About
Consolidated Balance Sheets (unaudited, in thousands, except share and per share data) |
||||||||
|
As of |
|||||||
|
2021 |
|
2020 |
|||||
Assets |
|
|
|
|||||
Cash and cash equivalents |
$ |
98,398 |
|
|
$ |
34,401 |
|
|
Accounts receivable, net |
|
15,713 |
|
|
|
10,024 |
|
|
Settlement assets |
|
21,880 |
|
|
|
14,308 |
|
|
Prepaid expenses |
|
7,436 |
|
|
|
927 |
|
|
Related party loan receivable, current |
|
14 |
|
|
|
600 |
|
|
Other current assets |
|
14,201 |
|
|
|
3,404 |
|
|
Total current assets |
|
157,642 |
|
|
|
63,664 |
|
|
Capitalized software, net |
|
6,359 |
|
|
|
3,722 |
|
|
Property and equipment, net |
|
15,930 |
|
|
|
15,363 |
|
|
Lease right-of-use assets |
|
2,202 |
|
|
|
3,733 |
|
|
Deferred tax assets, net |
|
370 |
|
|
|
418 |
|
|
Other assets |
|
710 |
|
|
|
833 |
||
Total assets |
$ |
183,213 |
|
|
$ |
87,733 |
|
|
Liabilities, convertible preferred stock and stockholders' equity (deficit) |
|
|
|
|||||
Accounts payable |
$ |
3,752 |
|
|
$ |
2,328 |
|
|
Accrued expenses and other liabilities |
|
11,046 |
|
|
|
3,535 |
|
|
Borrowings under line of credit |
|
15,000 |
|
|
|
15,000 |
|
|
Current portion of long-term debt, net of issuance costs |
|
549 |
|
|
|
2,454 |
|
|
Lease liabilities, current |
|
1,549 |
|
|
|
1,575 |
|
|
Settlement liabilities |
|
21,680 |
|
|
|
14,308 |
|
|
Total current liabilities |
|
53,576 |
|
|
|
39,200 |
|
|
Lease liabilities, non-current |
|
802 |
|
|
|
2,350 |
|
|
Deferred tax liabilities, net |
|
— |
|
|
|
916 |
|
|
Other liabilities |
|
153 |
|
|
|
877 |
|
|
Long-term debt, net of issuance costs |
|
52,067 |
|
|
|
30,321 |
|
|
Total liabilities |
|
106,598 |
|
|
|
73,664 |
|
|
Commitments and contingencies (Note 12) |
|
|
|
|||||
Convertible preferred stock, par value |
|
— |
|
|
|
45,105 |
|
|
Stockholders' equity (deficit): |
|
|
|
|||||
Common stock, par value |
|
6 |
|
|
|
— |
|
|
Additional paid-in capital |
|
142,515 |
|
|
|
21,312 |
|
|
Accumulated deficit |
|
(65,906 |
) |
|
|
(52,348 |
) |
|
Total stockholders' equity (deficit) |
|
76,615 |
|
|
|
(31,036 |
) |
|
Total liabilities, convertible preferred stock and stockholders' equity (deficit) |
$ |
183,213 |
|
|
$ |
87,733 |
|
|
|
|
|
|
Consolidated Statements of Income (unaudited, in thousands, except share and per share data) |
||||||||||||||||
|
|
Three months ended |
Year ended |
|||||||||||||
|
|
2021 |
|
2020 |
2021 |
|
2020 |
|||||||||
Revenue |
$ |
40,364 |
|
|
$ |
25,737 |
|
$ |
142,835 |
|
|
$ |
88,072 |
|
||
Cost of revenue, net(1)(2) |
|
19,925 |
|
|
|
8,533 |
|
|
53,693 |
|
|
|
32,414 |
|
||
Gross margin |
|
20,439 |
|
|
|
17,204 |
|
|
89,142 |
|
|
|
55,658 |
|
||
Operating expenses: |
|
|
|
|
|
|
||||||||||
Research and development(1)(2) |
|
2,850 |
|
|
|
2,083 |
|
|
10,988 |
|
|
|
6,728 |
|
||
General and administrative(1)(2) |
|
24,915 |
|
|
|
8,655 |
|
|
60,742 |
|
|
|
33,372 |
|
||
Sales and marketing(1)(2) |
|
13,109 |
|
|
|
2,074 |
|
|
27,664 |
|
|
|
9,888 |
|
||
Total operating expenses |
|
40,874 |
|
|
|
12,812 |
|
|
99,394 |
|
|
|
49,988 |
|
||
(Loss) income from operations |
|
(20,435 |
) |
|
|
4,392 |
|
|
(10,252 |
) |
|
|
5,670 |
|
||
Interest and other expenses, net |
|
(920 |
) |
|
|
(558 |
) |
|
(3,480 |
) |
|
|
(2,718 |
) |
||
(Loss) income before income taxes |
|
(21,355 |
) |
|
|
3,834 |
|
|
(13,732 |
) |
|
|
2,952 |
|
||
Benefit (provision) for income taxes |
|
(532 |
) |
|
|
(2,092 |
) |
|
174 |
|
|
|
(4,662 |
) |
||
Net (loss) income |
$ |
(21,887 |
) |
|
$ |
1,742 |
|
$ |
(13,558 |
) |
|
$ |
(1,710 |
) |
||
|
|
|
|
|
|
|
||||||||||
Less: income allocated to participating securities |
|
— |
|
|
|
(1,742 |
) |
|
— |
|
|
|
— |
|
||
Net loss attributable to Class A, LT10 and LT50 common stockholders |
$ |
(21,887 |
) |
|
$ |
— |
|
$ |
(13,558 |
) |
|
$ |
(1,710 |
) |
||
Net loss per share attributable to Class A, LT10 and LT50 common stockholders: |
|
|
|
|
|
|
||||||||||
Basic and diluted |
$ |
(0.82 |
) |
|
$ |
— |
|
$ |
(0.36 |
) |
|
$ |
(0.06 |
) |
||
Weighted-average shares of common stock used to compute net loss per share attributable to Class A, LT10 and LT50 common stockholders: |
|
|
|
|
|
|
||||||||||
Basic and diluted |
|
26,776,561 |
|
|
|
28,402,996 |
|
|
38,039,222 |
|
|
|
27,424,480 |
|
||
|
|
|
|
|
|
|
(1) Includes stock-based compensation expense as follows: |
||||||||||||
|
Three months ended |
Year ended |
||||||||||
|
2021 |
|
2020 |
2021 |
|
2020 |
||||||
|
(in thousands) |
(in thousands) |
||||||||||
Cost of revenue, net |
$ |
6,238 |
|
$ |
992 |
$ |
4,115 |
|
$ |
2,272 |
||
Research and development |
|
1,135 |
|
|
1,167 |
|
1,617 |
|
|
2,469 |
||
General and administrative |
|
1,262 |
|
|
2,443 |
|
7,356 |
|
|
12,648 |
||
Sales and marketing |
|
3,445 |
|
|
284 |
|
1,486 |
|
|
448 |
||
Total stock-based compensation expense |
$ |
12,080 |
|
$ |
4,886 |
$ |
14,574 |
|
$ |
17,837 |
||
|
|
|
|
|
|
|
(2) Includes IPO-related bonus expense as follows: |
||||||||||||
|
Three months ended |
Year ended |
||||||||||
|
2021 |
|
2020 |
2021 |
|
2020 |
||||||
|
(in thousands) |
(in thousands) |
||||||||||
Cost of revenue, net |
$ |
6,466 |
|
$ |
— |
$ |
13,708 |
|
$ |
— |
||
Research and development |
|
1,080 |
|
|
— |
|
8,550 |
|
|
— |
||
General and administrative |
|
1,899 |
|
|
— |
|
21,174 |
|
|
— |
||
Sales and marketing |
|
4,746 |
|
|
— |
|
4,984 |
|
|
— |
||
Total stock-based compensation expense |
$ |
14,190 |
|
$ |
— |
$ |
48,416 |
|
$ |
— |
||
Consolidated Statements of Cash Flows (unaudited, in thousands) |
||||||||
|
|
Year Ended |
||||||
|
|
2021 |
|
2020 |
||||
Cash flows from operating activities: |
|
|
|
|||||
Net (loss) income |
$ |
(13,558 |
) |
|
$ |
(1,710 |
) |
|
Adjustments to reconcile net loss to net cash provided by operating activities: |
|
|
|
|||||
Depreciation and amortization |
|
5,197 |
|
|
|
3,248 |
|
|
Reduction of operating lease right-of-use assets |
|
741 |
|
|
|
1,311 |
|
|
Loss on impairment, receivables and sale or disposal of equipment |
|
319 |
|
|
|
162 |
|
|
Stock-based compensation |
|
14,574 |
|
|
|
17,837 |
|
|
Amortization of debt issuance costs |
|
32 |
|
|
|
32 |
|
|
Deferred tax assets |
|
48 |
|
|
|
2,437 |
|
|
Deferred tax liabilities |
|
(916 |
) |
|
|
916 |
|
|
Changes in assets and liabilities: |
|
|
|
|||||
Accounts receivable |
|
(6,006 |
) |
|
|
(2,170 |
) |
|
Settlement assets |
|
173 |
|
|
|
2,878 |
|
|
Prepaid expenses |
|
(6,509 |
) |
|
|
270 |
|
|
Other current assets |
|
(4,100 |
) |
|
|
(1,393 |
) |
|
Related party loan receivable |
|
586 |
|
|
|
— |
|
|
Other assets |
|
124 |
|
|
|
(248 |
) |
|
Accounts payable |
|
1,424 |
|
|
|
(714 |
) |
|
Accrued expenses and other liabilities |
|
7,511 |
|
|
|
1,774 |
|
|
Operating lease liabilities |
|
(801 |
) |
|
|
(1,374 |
) |
|
Settlement liabilities |
|
7,372 |
|
|
|
(16,548 |
) |
|
Other liabilities |
|
(725 |
) |
|
|
877 |
|
|
Net cash provided by operating activities |
|
5,486 |
|
|
|
7,585 |
|
|
Cash flows from investing activities: |
|
|
|
|||||
Purchase of property and equipment |
|
(2,706 |
) |
|
|
(2,488 |
) |
|
Proceeds from sale or disposal of property and equipment |
|
— |
|
|
|
2 |
|
|
Software development costs |
|
(4,908 |
) |
|
|
(1,809 |
) |
|
Net cash used by investing activities |
|
(7,614 |
) |
|
|
(4,295 |
) |
|
Cash flows from financing activities: |
|
|
|
|||||
Principal payments of finance leases |
|
(774 |
) |
|
|
(808 |
) |
|
Principal payments of term loan |
|
(25,191 |
) |
|
|
(319 |
) |
|
Proceeds from term loan |
|
45,000 |
|
|
|
— |
|
|
Principal payments of line of credit |
|
— |
|
|
|
(1,000 |
) |
|
Proceeds from line of credit |
|
— |
|
|
|
9,613 |
|
|
Repurchases of common stock |
|
— |
|
|
|
— |
|
|
Vesting of restricted common stock |
|
567 |
|
|
|
— |
|
|
Proceeds from initial public offering, net of underwriters' discounts and commissions |
|
57,458 |
|
|
|
— |
|
|
Proceeds from issuance of common stock on exercise of stock options |
|
3,505 |
|
|
|
1,301 |
|
|
Net cash provided by financing activities |
|
80,565 |
|
|
|
8,787 |
|
|
Net increase in cash and cash equivalents |
|
78,437 |
|
|
|
12,077 |
|
|
Cash and cash equivalents and restricted cash, beginning of period |
|
46,878 |
|
|
|
34,801 |
|
|
Cash and cash equivalents and restricted cash, end of period |
$ |
125,315 |
|
|
$ |
46,878 |
|
|
Supplemental disclosure of cash flow information: |
|
|
|
|||||
Cash paid for interest |
$ |
3,082 |
|
|
$ |
2,929 |
|
|
Cash paid for income taxes |
$ |
6,922 |
|
|
$ |
150 |
|
|
Noncash investing and financing items: |
|
|
|
|||||
Commercial building and land acquired with long-term debt (net of issuance costs of |
$ |
— |
|
|
$ |
— |
|
|
Right-of-use assets acquired with lease liabilities |
$ |
— |
|
|
$ |
1,260 |
|
|
Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets |
|
|
|
|||||
Cash and cash equivalents |
$ |
98,398 |
|
|
$ |
34,401 |
|
|
Restricted cash included in other current assets |
|
8,651 |
|
|
|
1,955 |
|
|
Restricted cash included in other assets |
|
47 |
|
|
|
48 |
|
|
Restricted cash included in settlement assets |
|
18,219 |
|
|
|
10,474 |
|
|
Total cash, cash equivalents and restricted cash |
$ |
125,315 |
|
|
$ |
46,878 |
|
|
|
|
|
|
Reconciliation of GAAP to Non-GAAP Financial Measures (unaudited, in thousands) |
|||||||||||||||
Adjusted EBITDA |
|||||||||||||||
|
Three months ended |
|
Year ended |
||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||
|
(in thousands, except percentages) |
(in thousands, except percentages) |
|||||||||||||
Net (loss) income |
$ |
(21,887 |
) |
|
$ |
1,742 |
$ |
(13,558 |
) |
|
$ |
(1,710 |
) |
||
Add: |
|
|
|
|
|
|
|||||||||
(Benefit) provision for income taxes |
$ |
532 |
|
|
$ |
2,092 |
|
(174 |
) |
|
|
4,662 |
|
||
Interest and other expenses, net |
|
920 |
|
|
|
558 |
|
3,497 |
|
|
|
2,718 |
|
||
Depreciation and amortization |
|
1,465 |
|
|
|
895 |
|
5,197 |
|
|
|
3,248 |
|
||
Stock-based compensation |
|
12,079 |
|
|
|
4,886 |
|
14,574 |
|
|
|
17,837 |
|
||
Adjusted EBITDA |
$ |
(6,891 |
) |
|
$ |
10,173 |
$ |
9,536 |
|
|
$ |
26,755 |
|
||
|
|
|
|
|
|
|
Adjusted EBITDA Excluding the IPO-Related Bonus |
|||||||||||||||
|
Three months ended |
|
Year ended |
||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||
|
(in thousands, except percentages) |
(in thousands, except percentages) |
|||||||||||||
Net (loss) income |
$ |
(21,887 |
) |
|
$ |
1,742 |
$ |
(13,558 |
) |
|
$ |
(1,710 |
) |
||
Add: |
|
|
|
|
|
|
|||||||||
(Benefit) provision for income taxes |
$ |
532 |
|
|
$ |
2,092 |
|
(174 |
) |
|
|
4,662 |
|
||
Interest and other expenses, net |
|
920 |
|
|
|
558 |
|
3,497 |
|
|
|
2,718 |
|
||
Depreciation and amortization |
|
1,465 |
|
|
|
895 |
|
5,197 |
|
|
|
3,248 |
|
||
Stock-based compensation |
|
12,079 |
|
|
|
4,886 |
|
14,574 |
|
|
|
17,837 |
|
||
IPO-related bonus expense |
|
14,190 |
|
|
|
— |
|
48,416 |
|
|
|
— |
|
||
Adjusted EBITDA Excluding the IPO-Related Bonus |
$ |
7,299 |
|
|
$ |
10,173 |
$ |
57,952 |
|
|
$ |
26,755 |
|
||
|
|
|
|
|
|
|
Non-GAAP net income |
|||||||||||||||
|
Three months ended |
|
Year ended |
||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||
|
(in thousands, except percentages) |
(in thousands, except percentages) |
|||||||||||||
Net (loss) income |
$ |
(21,887 |
) |
|
$ |
1,742 |
$ |
(13,558 |
) |
|
$ |
(1,710 |
) |
||
Add: |
|
|
|
|
|
|
|||||||||
Stock-based compensation |
|
12,079 |
|
|
|
4,886 |
|
14,574 |
|
|
|
17,837 |
|
||
IPO-related bonus expense |
|
14,190 |
|
|
|
— |
|
48,416 |
|
|
|
— |
|
||
Non-GAAP net income |
$ |
4,382 |
|
|
$ |
6,628 |
$ |
49,432 |
|
|
$ |
16,127 |
|
||
|
|
|
|
|
|
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20220330005845/en/
Investor Relations Contact
investors@expensify.com
Press Contact
press@expensify.com
Source: